The feasibility of proteomics sequencing based immune-related prognostic signature for predicting clinical outcomes of bladder cancer patients

BACKGROUND: Bladder cancer (BCa) shows its potential immunogenity in current immune-checkpoint inhibitor related immunotherapies. However, its therapeutic effects are improvable and could be affected by tumor immune microenvironment. Hence it is interesting to find some more prognostic indicators fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Liren, Chen, Siteng, Pan, Qi, Zheng, Jun, He, Jin, Sun, Juanjuan, Han, Yaqin, Yang, Jiji, Zhang, Ning, Fu, Guohui, Gao, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210750/
https://www.ncbi.nlm.nih.gov/pubmed/35725413
http://dx.doi.org/10.1186/s12885-022-09783-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210750/
https://www.ncbi.nlm.nih.gov/pubmed/35725413
http://dx.doi.org/10.1186/s12885-022-09783-y

Ejemplares similares